Germany Medical Devices & Instruments Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Medical Devices & Instruments
Siemens Healthineers AG (SMMNY) Q3 2024 Earnings Call Transcript Highlights: Revenue Growth, Margins, and China Impact
Key takeaways from Siemens Healthineers AG (SMMNY) Q3 2024 earnings call, including revenue growth, margin performance, and challenges in China. Aug 01, 2024
Medical Devices & Instruments
Draegerwerk AG & Co KGaA (DGWPF) Q2 2024 Earnings Call Transcript Highlights: Strong Earnings Growth Amid Mixed Division Performance
Despite challenges in the medical division, Draegerwerk AG & Co KGaA (DGWPF) reports solid earnings and improved financial metrics in Q2 2024. Jul 26, 2024